Based in the UK, Douglas has over 20 years of clinical research experience, has been working globally in Project Management since 2003, and has 14 years in leadership roles. He has extensive experience working in peri/post approval research and has overseen many different types of studies, including observational, PASS and PAES, health outcomes studies, marketing studies, Expanded Access/Compassionate Use Programs, phase IIIb and phase IV studies, as well as paediatric studies. Douglas leads the Access team, responsible for Expanded Access/Compassionate Use Programs, as well as extended Access/Open Label Extension studies. He is an expert in the regulations and nuances of these types of studies as they require a different expertise and operational model as compared to phase III studies.
Douglas has worked as a Project Director for i3 Research, overseeing oncology studies and prior to that worked for six years at Quintiles as a Project Manager/Project Director, specializing in peri/post approval research. He also worked for Serono Pharmaceuticals as a Clinical Research Manager/Medical Manager for four years, conducting medical marketing research and Schering Plough for six years where he began his career in clinical.
Douglas has a degree in applied biological sciences. His clinical and therapeutic experience includes oncology, neurology, endocrinology, gastroenterology/liver disease, rheumatology, urology, infectious and respiratory disease. Douglas has also worked in drug discovery, developed pharmaceutical medicines through phase’s I-IV and managed medical device studies.